Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults

Publication | Closed Access

DOI

Citations

References

2007

Year

Rosa Antonijoan, Consuelo García‐Gea, Montserrat Puntes, J A Ruiperez Perez, Ramón Esbrí, Cristina Helena dos Reis Serra, J Fortea, M.J. Barbanoj

Clinical Therapeutics

Pharmacological StudyEbastine Fast-dissolving TabletPharmacologyPharmacotherapyMedicineDrug AllergyNonatopic AdultsPharmacokineticsCutaneous Histamine ReactionSide Effect